Tag: Lymphatic filariasis

According to the World Health Organization, millions of people worldwide suffer from neglected tropical diseases caused by parasitic worms. A powerful combination medication targeting these infections is ivermectin and albendazole suspension, which is prescribed for both humans and animals to treat a range of parasitic diseases.

Over 883 million people worldwide remain at risk for lymphatic filariasis (LF), a disabling parasitic disease targeted for elimination. As part of the global effort to combat this disease, the question of **is albendazole used for filariasis** is critical, as it plays an essential role in mass drug administration (MDA) strategies.

Since its donation by Merck & Co. began in 1987, the Mectizan Donation Program has provided over 4.4 billion treatments to combat devastating parasitic diseases worldwide. But **what is the drug Mectizan used for**? Primarily, it is a key medication in the fight against river blindness (onchocerciasis) and lymphatic filariasis, saving millions from blindness and disfigurement.

Hetrazan Tablet, containing the active ingredient Diethylcarbamazine Citrate (DEC), is a powerful anthelmintic agent used primarily to treat a range of parasitic worm infections. This medication works by targeting and eliminating both the larval and adult forms of specific parasitic worms, making it a key component in combating diseases like filariasis and tropical pulmonary eosinophilia.